We want our users to find Melo as easy to use as possible. For example, that means you should be able to:

- change colours, contrast levels and fonts using browser or device settings

- zoom in up to 400% without the text spilling off the screen

- navigate most of Melo using a keyboard or speech recognition software

- listen to most of Melo using a screen reader (including the most recent versions of JAWS, NVDA and VoiceOver)

We’ve also made the text on Melo as simple as possible to understand. If you find any problems not listed on this page or think we’re not meeting accessibility requirements, contact:support@decently.co.uk

If you need information on Melo in a different format like accessible PDF, large print, easy read, audio recording or braille then please email support@decently.co.uk. We’ll do our best to consider your request and get back to you in 5 working days.

Melo is fully compliant with the Web Content Accessibility Guidelines version 2.1 AA standard.

Melo aligns with the National Institute for Health and Care Excellence (NICE) Essential Service Framework (ESF) guidelines - as a Tier 3a digital health technology.

We are eager and happy to help verify and fix any bugs - we take pride in it! Create an issue by contacting support@decently.co.uk, providing as much information as you can about how to replicate the problem you're experiencing. We'll try to replicate the bug to verify, and if successful lodge the report for you. We'll also try to construct workarounds if possible.

Whilst we are only a small team, then we will seek to fix the most critical bugs affecting the widest set of users first. Bugs are triaged and prioritised (highest to low) based on the impact to users /patients.

Overt Aggression Scale-Modified for Neurorehabilitation (OAS-MNR)

We are pleased to confirm that we have obtained permission from the author, Professor Nick Alderman to incorporate The Overt Aggression Scale-Modified for Neurorehabilitation (OAS-MNR) within Melo for the availability to our users.

We extend our sincere gratitude to Nick for his cooperation and support in enabling us to make this recognised and trusted assessment tool accessible in a digital format through our platform.

St Andrew's Sexual Behaviour Assessment (SASBA)

We are pleased to confirm that we have obtained permission from the authors (Knight, Alderman, Johnson, Green, Birkett-Swan & Yorston, 2008) and St Andrews Healthcare to incorporate the St Andrew's Sexual Behaviour Assessment (SASBA) within Melo for the availability to our users.

We extend our sincere gratitude for their cooperation and support in enabling us to make this recognised and trusted assessment tool accessible in a digital format through our platform.

Melo has been co-designed and clinically validated to help healthcare teams make informed decisions about a patients' behaviours and provide a range of features and tools to support an evidenced based decision making approach.

Melo includes a clinical calculator (the Agitated Behaviour Scale) to assist users in making informed health-related calculations.

At Melo, we recognise the profound responsibility that comes with handling patient data. Misuse or mishandling of such data can lead to significant risks, including:

• Misdiagnosis or Delayed Treatment: Incorrect or incomplete data can result in inappropriate clinical decisions.

• Privacy Breaches: Unauthorised access to sensitive information can compromise patient confidentiality.

• Erosion of Trust: Patients may lose confidence in digital health solutions if their data is not managed responsibly.

To mitigate these risks, we place clinical safety at the forefront of our operations. We adhere to the DCB0129 clinical risk management standard, as mandated by the Health and Social Care Act 2012.

This standard outlines the necessary processes for manufacturers of health IT systems to identify, assess, and manage potential clinical risks associated with their products.

For more information please see: https://www.melo.health/dcb

Please feel free to reach out to us with any concerns or feedback. We value your input and are committed to improving Melo based on user suggestions. You can contact us at support@decently.co.uk

Melo is free at the point of care. We are funded through a combination of organisational level licence and implementation agreements.

Melo collects patient data, but rest assured, we prioritise user privacy and follow strict data protection regulations (eg, DTAC). Your data is handled securely, and you have control over what information you share.

We do not knowingly solicit data from or market to children under 18 years of age. If we learn that personal information from users less than 18 years of age has been collected, we will take reasonable measures to promptly delete such data from our records. If you become aware of any data we may have collected from children under age 18, please contact us at support@decently.co.uk

We take data security seriously and have implemented robust measures to safeguard your information. Your data is encrypted and protected according to industry best practices.

More information can be found within our Privacy policy

Melo adheres to currently recognised web design standards, including accessibility standards, to ensure inclusivity and usability.

We are proud to be endorsed by a number of leading healthcare organisations across the UK - including Elysium Healthcare, the Royal Hospital for Neuro-Disability, and a number of NHS Trusts.

This is testament to our commitment to providing a reliable and value-add digital service.

“Over the past 12 months, we’ve been working with Decently to roll out Melo across our services. We've collaborated closely with the product team to ensure it’s designed and built in the right way—so we can ultimately use it across our hospital to support better decision-making for patients. It’s also given us the gift of time.” - Professor Nick Alderman, Clinical Director, Elysium Neurological.

“We are thrilled that the neuro behavioural service at the RHN has partnered with Decently. Melo is such an important, useful and exciting development in the world of managing behaviour that challenges. Melo is a straightforward and clear app to track behaviour that challenges after brain injury. This will help us improve the data collection and how we utilise the data on our wards” - Dr Alex Rose, Principal Clinical Psychologist, Royal Hospital for Neuro-disability.

Melo has undergone rigorous testing and evaluation processes to ensure its quality and effectiveness. We are dedicated to continuously improving and providing the best user experience.

Melo is not classed as a medical device but serves as a clinical decision support tool (in line with MHRA guidelines).

This position has been verified with a number of organisations in the last 6 months - including ORCHA & Liverpool University Hospitals Group.

Melo does not currently send push or email notifications. If these were to be introduced in the future we would ensure they are customisable to suit your preferences.

A team of suitably qualified professionals has been actively involved in the development of Melo to ensure its accuracy and reliability. This includes our Clinical Safety Officer and Data Protection Officer.

If you require access to our risk log, please contact us, and we will provide you with the necessary information.

Melo does not automate treatment pathways. Any medical decisions will remain to be made by an appropriate qualified healthcare professional.

While we offer valuable health information and resources, Melo does not provide direct treatment for specific medical conditions. Always consult a healthcare professional for personalised advice.

User feedback and input have been integral to the design phase of Melo. Your suggestions have played a significant role in shaping our features and functionality.